July 23, 2016
Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.






Excessive topical application of FABIOR Foam may lead to marked redness, peeling, or discomfort [see WARNINGS AND PRECAUTIONS]. Management of accidental ingestion or excessive application to the skin should be as clinically indicated.


FABIOR Foam is contraindicated in pregnancy.

FABIOR Foam may cause fetal harm when administered to a pregnant woman.

Tazarotene elicits teratogenic and developmental effects associated with retinoids after topical or systemic administration in rats and rabbits [see Use in Specific Populations].

If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, treatment should be discontinued and the patient apprised of the potential hazard to the fetus [see WARNINGS AND PRECAUTIONS, Use In Specific Populations].

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 4/12/2016


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.

Health Resources
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations